Evidence map›Paper›PMID 42338729›Full record

ArticleFrontiers in cardiovascular medicine2026

High prevalence of thyroid nodules and their association with cardiometabolic risk in Mongolia.

Oyuntugs Byambasukh, Anar Bayarmunkh, Tsakhim-Erdene Tsendjav, Tugsjargal Purevsukh, Tuvshinjargal Dashjamts, Batzorig Bayartsogt, Enkhtur Yadamsuren, Altaisaikhan Khasag, Oyunsuren Enebish, Tumur-Ochir Tsedev-Ochir

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Oyuntugs Byambasukh *Department of Endocrinology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Anar Bayarmunkh *Department of Endocrinology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Tsakhim-Erdene TsendjavDepartment of Radiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Tugsjargal PurevsukhDepartment of Radiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Tuvshinjargal DashjamtsDepartment of Radiology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Batzorig BayartsogtDepartment of Epidemiology and Biostatistics, School of Public Health, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Enkhtur YadamsurenMongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Altaisaikhan KhasagDepartment of Endocrinology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.
Oyunsuren EnebishMinistry of Health of Mongolia, Ulaanbaatar, Mongolia.
Tumur-Ochir Tsedev-OchirState Central Third Hospital, Ulaanbaatar, Mongolia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Mongolia faces rising rates of obesity, diabetes, and cardiovascular disease, yet little is known about their relationship with thyroid nodules. This study aimed to assess the prevalence of thyroid nodules and their association with cardiometabolic outcomes in the Mongolian population. Methods: A nationwide retrospective analysis was conducted among 36,395 adults who underwent thyroid ultrasound during routine health checkups. Demographic, anthropometric, and metabolic parameters were recorded, including body mass index (BMI), central obesity, blood pressure, diabetes, and cardiovascular risk based on WHO criteria. Results: Thyroid nodules were identified in 40.3% ( Conclusions: Thyroid nodules are highly prevalent in Mongolia and cluster with adverse cardiometabolic outcomes. Nodules may serve as a clinical marker of elevated cardiovascular risk. Future longitudinal studies should explore potential bidirectional pathways between obesity, thyroid nodules, and cardiometabolic disease.

Indexed as

cardiovascular diseasesdiabeteshealth checkupsMongoliaobesitythyroid nodules

Identifiers

PMID42338729
PMCPMC13283884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.